Drug Type Small molecule drug |
Synonyms Aganepag, Aganepag isopropyl (USAN), AGN-210961 |
Target |
Action agonists |
Mechanism EP2 agonists(Prostanoid EP2 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H37NO4S |
InChIKeyGKRBCKDGBDUAIQ-URXFXBBRSA-N |
CAS Registry910562-20-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma, Open-Angle | Phase 2 | United States | 01 Jun 2010 |
Phase 2 | 163 | (Part 1, AGN-210961 Formulation 1) | aqfuuqfolx(mbkzuafmom) = nphzykvayh lcepiyekfx (rcwhsnypsi, 2.5) View more | - | 05 Aug 2014 | ||
(Part 1, AGN-210961 Formulation 2) | aqfuuqfolx(mbkzuafmom) = qergpelebw lcepiyekfx (rcwhsnypsi, 2.71) View more |